Anabond Stedman Pharma Research Private Limited - Company Profile

It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2004.
2004 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Anabond Stedman Pharma Research Private Limited

Anabond Stedman Pharma Research Private Limited, a active private limited company, was established on 09 November 2004 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U33112TN2004PTC054628. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹8.95 M.

It upholds a compliant status. Its leadership includes Ramkumar Rajagopal (Director), Abraham Mathew Sankarathil (Director), Rajagopal Rangachari (Director). Past directors included Esakiapillai Srinivasan, Abraham Mathew Sankarathil, Janakiraman Vijayakumar. It holds no open charges and ₹4.50 M settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.14A, Nehru Nagar Third Cross Street, Kottivakkam, Chennai, Tamil Nadu, 600041.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33112TN2004PTC054628

  • Registration Number

    054628

  • Incorporation Date

    09 November 2004

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹8.95 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 8.95 M
  • Company Age 21 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 4.50 M
  • Revenue Growth **** 34.65%
  • Profit Growth **** 57.58%
  • Ebitda **** -58.40%
  • Net Worth 10.07%
  • Total Assets **** 29.13%
Company report

Anabond Stedman Pharma Research Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Anabond Stedman Pharma Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Anabond Stedman Pharma Research Private Limited?
Current Directors
Name Designation Appointment Date Status
Ramkumar Rajagopal Director 09 Nov 2004 Current
Abraham Mathew Sankarathil Director 16 Dec 2020 Current
Rajagopal Rangachari Director 09 Nov 2004 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 10 Sep 2018 Past
Pramod Abcsdd Additional Director 27 Dec 2020 Past
Pramod Abcsdd Director 30 Sep 2020 Past
Pramod Abcsdd Additional Director 29 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Anabond Stedman Pharma Research.

Anabond Stedman Pharma Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 34.65% increase. The company also saw a substantial improvement in profitability, with a 57.58% increase in profit. The company's net worth Soared by an impressive increase of 10.07%.

Anabond Stedman Pharma Research revenue growth over time
Anabond Stedman Pharma Research profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 34.65%
*******
*******
*******
*******
Revenue from Operations
*******
 34.81%
*******
*******
*******
*******
Total Assets
*******
 29.13%
*******
*******
*******
*******
Profit or Loss
*******
 57.58%
*******
*******
*******
*******
Net Worth
*******
 10.07%
*******
*******
*******
*******
EBITDA
*******
 -58.40%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Anabond Stedman Pharma Research?

Unlock access to Anabond Stedman Pharma Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹4,500,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Ltd. : 0.45 Cr
Latest Charge Details
Date Lender Amount Status
28 Apr 2005 Hdfc Bank Ltd. ₹4.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Anabond Stedman Pharma Research?

Unlock and access historical data on people associated with Anabond Stedman Pharma Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Anabond Stedman Pharma Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anabond Stedman Pharma Research's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Anabond Stedman Pharma Research
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Anabond Stedman Pharma Research Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was documented.

  • Charges

    Progress on A charge registered on 28 Apr 2005 via Charge ID 90288135 with Hdfc Bank Ltd. was fully satisfied on 17 Aug 2024. was documented.

  • Balance Sheet

    Anabond Stedman Pharma Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.

  • Director Appointment

    Abraham Mathew Sankarathil was appointed as a Director was appointed as a Director on 16 Dec 2020 & has been associated with this company since 5 years 2 months . was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Ltd. amounted to Rs. 0.45 Cr with Charge ID 90288135 was registered on 28 Apr 2005. was recorded as a recent event.

  • Director Appointment

    The activity Ramkumar Rajagopal was appointed as a Director was appointed as a Director on 09 Nov 2004 & has been associated with this company since 21 years 3 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Anabond Stedman Pharma Research Private Limited?

The CIN of Anabond Stedman Pharma Research Private Limited is U33112TN2004PTC054628.

Where is Anabond Stedman Pharma Research Private Limited headquartered?

Anabond Stedman Pharma Research Private Limited is headquartered at Plot No.14A, Nehru Nagar Third Cross Street, Kottivakkam, Chennai, Tamil Nadu, 600041.

When was Anabond Stedman Pharma Research Private Limited incorporated?

Anabond Stedman Pharma Research Private Limited was incorporated on 09 November 2004.

Who are the current directors of Anabond Stedman Pharma Research Private Limited?

The current directors of Anabond Stedman Pharma Research Private Limited are

What is the primary industry of Anabond Stedman Pharma Research Private Limited?

The primary industry of Anabond Stedman Pharma Research Private Limited is Pharma.

Is Anabond Stedman Pharma Research Private Limited a listed company?

Anabond Stedman Pharma Research Private Limited is unlisted.

What is the capital structure of Anabond Stedman Pharma Research Private Limited?

The authorized capital of Anabond Stedman Pharma Research Private Limited is ₹1.00 Cr, and the paid-up capital is ₹8.95 M.

What is the compliance status of Anabond Stedman Pharma Research Private Limited?

The compliance status of Anabond Stedman Pharma Research Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available